Bioadaptives (BDPT) Capital Expenditures (2014)

Bioadaptives' (BDPT) quarterly Capital Expenditures came in at $1583.0 in Q3 2014, little changed quarter-over-quarter from $1583.0 in Q2 2014.

Bioadaptives (BDPT) Capital Expenditures (2014) Analysis & Trends

Bioadaptives has disclosed Capital Expenditures across 1 years of filings, most recently posting $1583.0 for Q3 2014.

Capital Expenditures for Q3 2014 came in at $1583.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was $1583.0 (changed N/A YoY), and the FY2025 annual result was $18000.0, changed N/A from the prior year.
Capital Expenditures came in at $1583.0 for Q3 2014 at Bioadaptives, roughly flat from $1583.0 in the prior quarter.
In the past five years, Capital Expenditures ranged from a high of $1583.0 in Q2 2014 to a low of $1583.0 in Q2 2014.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Capital Expenditures (Qtr)
1	Paranovus Entertainment Technology	75,216.52 Bn	75,216.52 Bn	-	-
2	Kraft Heinz	26.76 Bn	22.68 Bn	2.22 Bn	240.00 Mn
3	General Mills	17.79 Bn	17.02 Bn	1.37 Bn	102.40 Mn
4	Jbs	13.93 Bn	9.37 Bn	2.32 Bn	-566.40 Mn
5	Hormel Foods	13.00 Bn	12.16 Bn	518.51 Mn	-1.96 Mn
6	Mccormick	12.70 Bn	13.10 Bn	708.90 Mn	32.50 Mn
7	Magnum Ice Cream	12.17 Bn	11.70 Bn	-	-415.56 Mn
8	J M Smucker	11.05 Bn	10.99 Bn	827.80 Mn	71.50 Mn
9	Smithfield Foods	10.57 Bn	9.49 Bn	511.00 Mn	88.00 Mn
10	Bioadaptives	-	-	4,113.00	-

Download Data